Morphing of Ibogaine: A Successful Attempt into the Search for Sigma-2 Receptor Ligands.
Ibogaine
Incazane
Pinoline
TMEM97
molecular docking
scaffold-hopping
sigma-2 receptor
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
23 Jan 2019
23 Jan 2019
Historique:
received:
31
12
2018
revised:
18
01
2019
accepted:
21
01
2019
entrez:
26
1
2019
pubmed:
27
1
2019
medline:
10
5
2019
Statut:
epublish
Résumé
Ibogaine is a psychoactive indole alkaloid with high affinity for several targets including the
Identifiants
pubmed: 30678129
pii: ijms20030488
doi: 10.3390/ijms20030488
pmc: PMC6386901
pii:
doi:
Substances chimiques
Ligands
0
Receptors, sigma
0
sigma-2 receptor
0
Ibogaine
3S814I130U
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Alkaloids Chem Biol. 2001;56:173-91
pubmed: 11705107
Cancer Res. 2002 Jan 1;62(1):313-22
pubmed: 11782394
Proteins. 2002 May 15;47(3):393-402
pubmed: 11948792
Drug News Perspect. 2002 Dec;15(10):617-625
pubmed: 12677246
Eur J Pharmacol. 1992 Dec 1;227(4):371-8
pubmed: 1359973
Brain Res. 1992 Feb 7;571(2):242-7
pubmed: 1377086
J Mol Model. 2004 Apr;10(2):155-64
pubmed: 14997367
Synapse. 2006 May;59(6):350-8
pubmed: 16463398
J Chem Inf Model. 2006 Mar-Apr;46(2):665-76
pubmed: 16562997
FASEB J. 2006 Nov;20(13):2420-2
pubmed: 17023388
Cell. 2007 Nov 2;131(3):596-610
pubmed: 17981125
Hum Exp Toxicol. 2008 Mar;27(3):181-94
pubmed: 18650249
Eur J Med Chem. 2011 Oct;46(10):5154-61
pubmed: 21899931
Synapse. 2012 Jul;66(7):630-9
pubmed: 22337473
Bioinformatics. 2014 Oct 15;30(20):2981-2
pubmed: 24996895
Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2703-14
pubmed: 25173780
J Chem Inf Model. 2015 Feb 23;55(2):460-73
pubmed: 25558886
Clin Toxicol (Phila). 2016;54(4):297-302
pubmed: 26807959
Nature. 2016 Apr 28;532(7600):527-30
pubmed: 27042935
Eur J Med Chem. 2017 Jan 5;125:603-610
pubmed: 27721146
J Med Chem. 2016 Nov 10;59(21):9960-9966
pubmed: 27739690
J Neurochem. 2017 Feb;140(4):561-575
pubmed: 27926996
Pharmacol Res. 2017 Mar;117:67-74
pubmed: 28007569
J Cheminform. 2017 Jan 21;9:3
pubmed: 28123452
Handb Exp Pharmacol. 2017;244:309-330
pubmed: 28176045
Adv Exp Med Biol. 2017;964:153-161
pubmed: 28315270
Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7160-7165
pubmed: 28559337
Eur J Pharm Sci. 2017 Aug 30;106:94-101
pubmed: 28571781
ACS Chem Neurosci. 2017 Aug 16;8(8):1801-1811
pubmed: 28644012
Data Brief. 2017 Jun 16;13:514-535
pubmed: 28702490
Eur J Med Chem. 2017 Oct 20;139:884-891
pubmed: 28866257
J Biomed Sci. 2017 Sep 16;24(1):74
pubmed: 28917260
J Med Chem. 2017 Dec 14;60(23):9531-9544
pubmed: 29172528
Future Med Chem. 2018 Jan;10(2):231-256
pubmed: 29185346
J Med Chem. 2018 Jan 11;61(1):372-384
pubmed: 29220177
ChemMedChem. 2018 Jul 6;13(13):1336-1342
pubmed: 29693778
Neuropsychopharmacology. 2018 Aug;43(9):1867-1875
pubmed: 29728649
Molecules. 2018 May 18;23(5):null
pubmed: 29783634
Bioorg Chem. 2018 Dec;81:334-339
pubmed: 30189413
Molecules. 2018 Aug 30;23(9):null
pubmed: 30200181
Mar Drugs. 2018 Oct 14;16(10):null
pubmed: 30322188
ACS Chem Neurosci. 2018 Nov 13;:null
pubmed: 30421909
Bioorg Chem. 2019 Mar;84:276-284
pubmed: 30529845
Data Brief. 2018 Dec 19;22:471-483
pubmed: 30619925
Acta Pharmacol Toxicol (Copenh). 1978 Nov;43(5):375-80
pubmed: 726902
Psychopharmacology (Berl). 1994 May;114(4):672-4
pubmed: 7531855
Eur J Pharmacol. 1995 Jun 6;279(1):R1-3
pubmed: 7556375
Pharmacol Rev. 1995 Jun;47(2):235-53
pubmed: 7568327
Psychopharmacology (Berl). 1995 Apr;118(4):369-76
pubmed: 7568622
Life Sci. 1995;57(4):PL57-62
pubmed: 7603301
Eur J Pharmacol. 1995 Jul 14;280(3):301-10
pubmed: 8566098